help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Enright, P. L.
Right arrow Articles by Lee, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enright, P. L.
Right arrow Articles by Lee, W. W.

Am. J. Respir. Crit. Care Med., Vol 151, No. 2, 02 1995, 406-411.

Spirometry in the Lung Health Study: II. Determinants of short-term intraindividual variability

PL Enright, JE Connett, RE Kanner, LR Johnson and WW Lee
Respiratory Sciences Center, University of Arizona, Tucson.

The Lung Health Study (LHS) is a randomized clinical trial designed to determine whether a smoking intervention program and use of an inhaled bronchodilator (BD) can reduce the rate of decline of FEV1 in cigarette smokers with airflow limitation. During recruitment, spirometry was performed at second and third screening visits, a mean of 21 d apart. A total of 5,887 smokers, 35 to 60 yr of age and of whom 63% were men, met the study eligibility requirements. Smokers taking physician- prescribed BDs or with an FEV1 < 50% or > 90% predicted were excluded, as were those whose FEV1/FVC ratio was greater than 70%. Two inhalations of isoproterenol were given to determine BD response during the second visit. A serial dilution methacholine challenge test was done during the third visit to determine nonspecific airway reactivity. Ninety-five percent of the differences between FEV1 measured at the two visits were within 240 ml for women and within 320 ml for men (coefficients of repeatability). The best independent predictors of the mean short-term (between visit) intraindividual FEV1 variability were factors indicating intrinsic airway reactivity of the participants: bronchodilator response, methacholine reactivity, and the presence of wheezing; as well as factors influenced by the quality of spirometry testing: the difference between the highest and second highest FEV1s and peak flows during baseline spirometry, and the time to reach peak flow (PEFT).


This article has been cited by other articles:


Home page
Occup. Environ. Med.Home page
E. Hnizdo, K. Sircar, T. Yan, P. Harber, J. Fleming, and H. W Glindmeyer
Limits of longitudinal decline for the interpretation of annual changes in FEV1 in individuals
Occup. Environ. Med., October 1, 2007; 64(10): 701 - 707.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. C. McCormack, D. Shade, and R. A. Wise
Spirometer Calibration Checks: Is 3.5% Good Enough?
Chest, May 1, 2007; 131(5): 1486 - 1493.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. B. Herpel, R. E. Kanner, S. M. Lee, H. E. Fessler, F. C. Sciurba, J. E. Connett, R. A. Wise, and for the Lung Health Study Research Group and the N
Variability of Spirometry in Chronic Obstructive Pulmonary Disease: Results from Two Clinical Trials
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1106 - 1113.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
S. Zanconato, G. Meneghelli, R. Braga, F. Zacchello, E. Baraldi, and on behalf of the Working Group
Office Spirometry in Primary Care Pediatrics: A Pilot Study
Pediatrics, December 1, 2005; 116(6): e792 - e797.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
E Hnizdo, L Yu, L Freyder, M Attfield, J Lefante, and H W Glindmeyer
The precision of longitudinal lung function measurements: monitoring and interpretation
Occup. Environ. Med., October 1, 2005; 62(10): 695 - 701.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency
Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 818 - 900.
[Full Text] [PDF]


Home page
ThoraxHome page
T R Schermer, J E Jacobs, N H Chavannes, J Hartman, H T Folgering, B J Bottema, and C van Weel
Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD)
Thorax, October 1, 2003; 58(10): 861 - 866.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. H. Sanders, A. B. Newman, C. L. Haggerty, S. Redline, M. Lebowitz, J. Samet, G. T. O'Connor, N. M. Punjabi, and E. Shahar
Sleep and Sleep-disordered Breathing in Adults with Predominantly Mild Obstructive Airway Disease
Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 7 - 14.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Decramer, P.N.R. Dekhuijzen, T. Troosters, C. van Herwaarden, M. Rutten-van Molken, C.P.O. van Schayck, D. Olivieri, I. Lankhorst, and A. Ardia
The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design
Eur. Respir. J., March 1, 2001; 17(3): 329 - 336.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. Eaton, S. Withy, J. E. Garrett, J. Mercer, R. M. L. Whitlock, and H. H. Rea
Spirometry in Primary Care Practice: The Importance of Quality Assurance and the Impact of Spirometry Workshops
Chest, August 1, 1999; 116(2): 416 - 423.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society